Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Jun X. Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8106-4775; OpenAlex author ID A5029316081. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. m6A Modification-Mediated LINC01547 Promotes Pancreatic Cancer Growth and Gemcitabine Resistance Through miR-34a-5p/MYH9 Axis. Last author DOI 10.1007/s10528-025-11254-5↗
  2. circ-1584 selectively promotes the antitumor activity of the oncolytic virus M1 on pancreatic cancer. Co-author DOI 10.1016/j.omton.2024.200919↗
  3. High KLK7 Expression Predicts Unfavorable Outcomes in Patients with Resectable Pancreatic Ductal Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-985162/v1↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guo‐Dong Lu · 1 shared paper, 2026 · strength 0.36
  2. Taofang Hao · 1 shared paper, 2025 · strength 0.23
  3. Guangmei Yan · 1 shared paper, 2025 · strength 0.23
  4. Jing Cai · 1 shared paper, 2025 · strength 0.23
  5. Rucheng Yao · 1 shared paper, 2021 · strength 0.14
  6. Jun Zheng · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.